The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Allen Pantuck, MD
University of California, Los Angeles
Principal Investigator - David F McDermott, MD
Beth Israel Deaconess Medical Center
Study Chair - Geoffrey Weiss, MD
University of Virginia
Principal Investigator - Janice Dutcher, MD
Our Lady of Mercy Cancer Center
Principal Investigator - Jeffrey Sosman, MD
Vanderbilt University
Principal Investigator - Joseph Clark, MD
Loyola University
Principal Investigator - Kim Margolin, MD
City of Hope National Medical Center
Principal Investigator - Leonard Appleman, MD
University of Pittsburgh
Principal Investigator - Leslie Oleksowicz, MD
University of Cincinnati
Principal Investigator - Marc Ernstoff, MD
Dartmouth-Hitchcock Medical Center
Principal Investigator - Michael Wong, MD
Roswell Park Cancer Institute
Principal Investigator - Theodore Logan, MD
Indiana University
Principal Investigator - Ulka Vaishampayan, MD
Wayne State University
Principal Investigator - Walter Urba, MD
Chiles Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2006
- Primary completion
- 31 Oct 2013
- Completion
- 31 Oct 2013
- Last update posted
- 28 Aug 2024
- Registered enrollment
- 123
- Registry id
- NCT00554515
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.